Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: Jolie Renee who wrote (56)	4/21/1998 9:25:00 AM
From: PAUL ROBERT ST. ONGE	Respond to of 127

I highly doubt that Astra-Merck would ignore this filing. I am sure this startled them to say the least. That being said, if history can prove anything for the future, then Andrx will walk the legal lines quite well. Litigation is part of the business, and is expected with each filing. What is interesting though, is that I do not believe Andrx was sued for either of the last two ANDA filings prior to Prilosec, which I believe would mean clear sailing on those two.